Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critica! translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation. |
Característiques principals
2013 RESEARCH FUNDING PRIORITIES The ADDF funds four different categories of research: FUNDING MECHANISMS |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
Convocatòria: http://www.alzdiscovery.org/research-and-grants/funding-opportunities Instruccions: http://www.alzdiscovery.org/research-and-grants/howtoapply |
Dotació
$150,000 |
Durada
1 year. In some cases, multi-year proposals can be considered. |
AVÍS IMPORTANT
Interested applicants must first submit a Letter of Intent electronically via the ADDF website (www.alzdiscovery.org), two weeks before the deadline. Deadline for complete applications is September 5th, 2013. |
Arxius
Arxiu |
---|